Adrenocorticotropic hormone versus methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trial

BACKGROUND: The objective of this study was to evaluate monthly intramuscular adrenocorticotropic hormone (ACTH) gel versus intravenous methylprednisolone (IVMP) add-on therapy to interferon β for breakthrough disease in patients with relapsing forms of multiple sclerosis. METHODS: This was a prospe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Neurol Disord
Autors principals: Berkovich, Regina, Bakshi, Rohit, Amezcua, Lilyana, Axtell, Robert C., Cen, Steven Y., Tauhid, Shahamat, Neema, Mohit, Steinman, Lawrence
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5400152/
https://ncbi.nlm.nih.gov/pubmed/28450891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616670060
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars